Skip to the main content.

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

Tom French : 28 July 2025

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

From Disruption to Reinvention: The Story of API-in-Capsule Technology and Its Future

This article traces the evolution of API-in-capsule (AIC) technology, from its early disruption of traditional formulation through the Xcelodose® system, to its reinvention in 3P innovation’s Fill2Weight platform. The authors explore how AIC has shifted from a risky bet to a scalable solution for modern drug development. Looking ahead, they highlight the transformative role AIC can play in personalised medicine, oncology, and DPI, where flexibility and precision are key to success.

Authors:

  • Tom French (Head of Process Technology- 3P innovation)
  • Dave Miller (CSO- AustinPx)
  • Derek Hennecke (CEO- Grand River Aseptic Manufacturing)

READ THE WHITEPAPER HERE
Putting Annex 1 into Practice: What Small-Batch Manufacturers Need to Know

Putting Annex 1 into Practice: What Small-Batch Manufacturers Need to Know

David Johnson: 7 January 2026

In this webinar recap, David Johnson, Sales & Marketing Director at 3P innovation, and Tracy Moore, Principal Consultant at TM Pharma and former...

Read More
The Future of Aseptic Manufacturing: Compact and Advanced Solutions

The Future of Aseptic Manufacturing: Compact and Advanced Solutions

David Johnson: 15 December 2025

As the pharmaceutical industry advances into more complex modalities, from biologics to cell and gene therapies, the need for flexible,...

Read More
Advancing DPI blister filling: from the original invention to the latest technology.

Advancing DPI blister filling: from the original invention to the latest technology.

Carl Jones: 14 November 2025

Our DPI blister filling capabilities draw on long-standing experience, our founder, Tom Bailey, is one of the named inventors of the DPI filling...

Read More